Technology | August 29, 2013

Bayer Launches New Jetstream XC and SC Atherectomy Catheters

The catheters can be used to treat PAD and multiple lesion morphologies


August 29, 2013 — Bayer HealthCare announced that the U.S. Food and Drug Administration (FDA) has cleared two new Jetstream atherectomy catheters. The SC (Single Cutter) atherectomy catheter is available in 1.6-mm and 1.85-mm cutting diameters.  The XC (eXpandable cutter) atherectomy catheter features both front cutting tip and expandable blade technology for use in larger vessels.  The XC is available in two cutting diameters: 2.1-mm blades down / 3.0-mm blades up and 2.4-mm blades down / 3.4-mm blades up.

Redesigned, integrated control pods feature:

  • Ergonomic design and smaller size (32 percent) for improved ease of use
  • New user interface to facilitate single or dual operator use 
  • Simplified guidewire management through improved wire GARD
  • Reduced storage space requirements and environmental impact through new control pod design and improved packaging

 

The Jetstream Atherectomy System is one of the most versatile debulking solutions for the treatment of peripheral artery disease (PAD).  The system catheters can be used to treat multiple lesion morphologies – from thrombus to the most challenging calcium deposits. Catheters are available in both SC and XC sizes to support treatment of vessels above and below the knee. The Jetstream System consists of a single-use catheter with control pod and a reusable, compact console that mounts to a standard IV stand. 

For more information: www.ri.bayer.com


Related Content

News | Cath Lab

December 20, 2023 — Jason R. McCarthy, Ph.D., associate professor of biomedical research and translational medicine and ...

Home December 20, 2023
Home
News | Cath Lab

October 26, 2023 — Royal Philips, a global leader in health technology, announced the latest results demonstrating the ...

Home October 26, 2023
Home
News | Cath Lab

October 25, 2023 — Shockwave Medical, Inc., a pioneer in the development and commercialization of transformational ...

Home October 25, 2023
Home
News | Cath Lab

October 20, 2023 — Over the coming days, Philips will be presenting its latest solutions in cardiology and new late ...

Home October 20, 2023
Home
News | Cath Lab

October 16, 2023 — GE HealthCare (Nasdaq: GEHC) announced US FDA 510(k) clearance of Allia IGS Pulse - the latest ...

Home October 16, 2023
Home
News | Cath Lab

October 16, 2023 — Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, announced the first U.S ...

Home October 16, 2023
Home
News | Cath Lab

September 13, 2023 — A diagnostic test, first offered in the United States at University Hospitals (UH) Harrington Heart ...

Home September 13, 2023
Home
News | Cath Lab

August 2, 2023 — Teleflex Incorporated, a leading global provider of medical technologies, announced the U.S Food and ...

Home August 02, 2023
Home
News | Cath Lab

July 13, 2023 — Mount Sinai Queens announced the opening of a new cardiac catheterization lab that will provide rapid ...

Home July 13, 2023
Home
News | Cath Lab

June 21, 2023 — Royal Philips, a global leader in health technology, announced it has teamed up with BIOTRONIK (Lake ...

Home June 21, 2023
Home
Subscribe Now